We have a New Trade we are getting into for our Weekly Wrap newsletter. We have followed the stock for years and we believe shares could double over the next 6-12 months.
The stock is just north of $3 and we have a Price Target of $6+.
We have a long history of recommending favorable biotech stocks and we believe our latest addition will be a triple-digit winner.
Subscribers, check the Weekly Wrap Premium section for the New Trade and we will be back shortly with our Daily.